views
Recent advances in the manufacturing technologies haveprompted pharmaceutical companies to consider shifting from the traditionalmulti-step, batch manufacturing processes to faster, and relatively moreefficient continuous manufacturing
Roots Analysis is pleased toannounce the publication of its recent study, titled, “Manufacturing Market Continuous(Small Molecules and Biologics), 2020 – 2030.”
The report features an extensive study of the currentmarket landscape and future opportunities for companies with capabilities incontinuous manufacturing (both innovator companies with in-house expertise andcontract manufacturers). It features an in-depth analysis, highlighting thecapabilities of various stakeholders engaged in this domain. In addition toother elements, the study includes:
§ A detailedassessment of the overall landscape of companies with capabilities forcontinuous manufacturing
§ Elaborateprofiles of some of the key contract manufacturers active in the pharmaceuticaland biopharmaceutical continuous manufacturing market
§ Ananalysis of the various partnerships related to continuous manufacturing, whichhave been established since 2013
§ Ananalysis of the expansions related to continuous manufacturing, which have beenestablished since 2013
§ Anestimate of the global, continuous manufacturing capacity, based on thecapacities of various industry stakeholders (as available on their respectivecompany websites).
§ Astudy of the various grants that have been awarded to research institutesengaged in projects related to continuous manufacturing, between 2014 and 2019
§ Anin-depth analysis of the various patents that have been filed / granted relatedto continuous manufacturing till 2019
§ Initiatives taken bythe leading pharmaceutical companies (in terms of revenues), covering bothpartnered as well as in-house projects.
§ A review of thecompanies offering modular facilities / modular cleanrooms
§ A case study of thecompanies offering technologies / equipment
§ A case study on theroadmap for the adoption of continuous manufacturing technique
§ A detailed market forecast, featuring analysis of thecurrent and projected future opportunity across key market segments (listedbelow)
§ Purposeof Manufacturing
§ In-House
§ Contract service
§ Scaleof Operation
§ Commercial
§ Preclinical / Clinical
§ Typeof Continuous Manufacturing related Service
§ APIManufacturing
§ EndProduct manufacturing
§ Typeof Drug Molecule
§ Biologic
§ Small Molecule
§ Typeof dosage form
§ Solid
§ Liquid
§ KeyGeographical Regions
§ North America
§ Europe
§ Asia Pacific
Keycompanies covered in the report- https://www.rootsanalysis.com/reports/308/request-sample.html
§ AbbVieContract Manufacturing
§ AjinomotoBio-Pharma Services
§ Almac
§ BoehringerIngelheim BioXcellence
§ Cambrex
§ CordonPharma
§ Hovione
§ Kaneka
§ Lonza
§ Patheon
§ SKbiotek
§ WuXiAppTec
Formore information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/continuous-manufacturing/308.html
Other Offerings
1. Pharmaceutical Contract ManufacturingMarket (2nd Edition), 2018-2028
2. Biopharma Contract Manufacturing Market (3rd Edition), 2019 - 2030
3. China Pharmaceutical Contract Manufacturing Services Market, 2020-2030
4. China Biopharmaceutical Contract Manufacturing Market, 2020 - 2030
About Roots Analysis
Roots Analysis is one of the fastest growingmarket research companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
Contact Information
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis